Skip to main content

$0.018 -0.001 (-5.26%)

High

$0.02

Low

$0.02

Trades

52

Turnover

$20,686

Volume

1,123,417
30 June 2023 at 4:10pm
Register to track BNO and receive email alerts.
Subject
BNO Ann: Proposed issue of securities - BNO

BNO Ann: Bionomics Announces Pricing of IPO in the US

BNO Ann: Trading Halt

BNO Ann: Pause in Trading

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: Bionomics Announces Launch of Proposed IPO in the US

BNO Ann: 2021 New Constitution

BNO Ann: 2021 AGM Results of Meeting

BNO Ann: 2021 AGM Executive Chairman's Presentation

BNO Ann: Fast Track Designation for BNC210 in Social Anxiety Disorder

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: BNO Files Registration Statement for Proposed IPO in the US

BNO Ann: Update on Possible Capital Distribution

BNO Ann: Bionomics Receives ASX Waiver from LR 10.13.5

BNO Ann: Section 708A Notice

BNO Ann: Application for quotation of securities - BNO

BNO Ann: FDA Clears BNC210 Ph2 Social Anxiety Disorder IND (PREVAIL)

BNO Ann: 2021 Notice of AGM/Proxy Form

BNO Ann: Quarterly Activities/Appendix 4C Cash Flow Report

BNO Ann: Jobkeeper Payments Notification

BNO Ann: 2021 Corporate Governance Statement and Appendix 4G

BNO Ann: 2021 Annual Report

BNO Ann: Closing Date for Nomination of Director

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: BNO prepares BNC210 for start of Phase 2 Acute SAD trial

BNO Ann: Cleansing Notice

BNO Ann: Application for quotation of securities - BNO

BNO Ann: Correction to Appendix 4E

BNO Ann: Full Year Statutory Accounts FY2021

BNO Ann: Preliminary Final Report FY2021 App 4E and Announcement

BNO Ann: BNO Announces Planned Capital Distribution to Shareholders

BNO Ann: BNO Announces Plans to Conduct U.S. Initial Public Offering

BNO Ann: Quarterly Activities and Cashflow Report

BNO Ann: Final Director's Interest Notice

BNO Ann: BNO Initiates Phase 2b ATTUNE Study of BNC210 in PTSD

BNO Ann: Initial Director's Interest Notice M. Davies

BNO Ann: Notification of cessation of securities - BNO

BNO Ann: Executive Chairman - New Employment Agreement

BNO Ann: Appointment and Resignation of Director

BNO Ann: Change of Telephone Number

BNO Ann: Change of Address

BNO Ann: Cleansing Notice

BNO Ann: Appendix 2A

BNO Ann: Corporate Presentation May 2021

BNO Ann: Bionomics BNC210 Expansion into Social Anxiety Disorder

BNO Ann: Bionomics Announces Early Repayment of Debt

BNO Ann: Quarterly Cashflow Report Mar 2021

BNO Ann: Change in substantial holding

BNO Ann: Appendix 3Y D Wilson

BNO Ann: Change in substantial holding

Register to track BNO and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX